Endocyte, Inc. (NASDAQ:ECYT) Signs Licensing Agreement

Endocyte, Inc. (NASDAQ:ECYT) Signs Licensing Agreement”

Endocyte, Inc. (NASDAQ:ECYT) recently saw its volume around 0.2 million shares and on average it trades 360.56 million shares a day. The stock has "Outperform" rating by Credit Suisse on Thursday, January 21.

Company shares are trading at $5.50 which is well above $1.42, the 50 day moving average and significantly higher than the 200 day moving average of $1.83. Of those analysts, no rate stock as a Strong Buy, 2 rate it as Hold, and just no analyst rates it as a Moderate Sell.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0, and a price to sales ratio of 0.33. Endocyte had 7 analyst reports since August 5, 2015 according to SRatingsIntel. (NASDAQ:ECYT) hit a new 52-week high and has $6.17 target or 6.00 % above today's $5.82 share price. Now trading with a market value of 154.29M, the company has a mix of catalysts and obstacles that spring from the nature of its operations.

This stock (ECYT) is ahead of its 52-week low with 20.51%. (NASDAQ:ECYT) were released by: and their article: "Options Traders Expect Huge Moves in Endocyte (ECYT) Stock" published on October 03, 2017 as well as's news article titled: "Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted ..." with publication date: October 02, 2017.

Endocyte, Inc. (NASDAQ:ECYT) shares have traded 159.29% for the week and are 42.35% for the year. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. The company's net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin. Over the past month the firm's stock is 40.99%, 118.27% for the last quarter, 127.00% for the past six-months and 86.07% for the a year ago. If Endocyte, Inc. (NASDAQ:ECYT) shares can stay above the price resistance around $4.38 a share, that could help propel Endocyte, Inc. The original version of this report can be read at

Inclusion of study data that describe the time-action profile by dosage strength, showing first measurable effect starts in around 12 minutes, peak effects occur around 35 to 45 minutes after dosing and return to baseline after around 1.5 to 3 hours for the 4 and 12 unit cartridges respectively. Its Average True Range (ATR) value figured out at 0.57. With 246,900 avg volume, 3 days are for Arcbest Corporation (NASDAQ:ARCB)'s short sellers to cover ARCB's short positions. Dimensional Fund Advisors LP now owns 98,313 shares of the biopharmaceutical company's stock worth $147,000 after acquiring an additional 25,003 shares during the last quarter. The stock now has Weekly Volatility of 28.62% and Monthly Volatility of 9.84%. RMB Capital Management LLC raised its position in shares of Endocyte by 8.8% in the 1st quarter.

11/04/2015 - Endocyte, Inc. had its "outperform" rating reiterated by analysts at RBC Capital.

According to Endocyte, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 28.79%.

Like this



04 October 2017
Former New Orleans Saints safety Jairus Byrd signs with Carolina Panthers
He has 546 tackles, four sacks, 25 interceptions, 40 passes defensed, 14 forced fumbles and six fumble recoveries. Last season with New Orleans, Byrd recorded 96 tackles, two interceptions and two passes defensed in 16 games.

04 October 2017
Jennifer Lopez Postpones Las Vegas Show Dates Out of Respect for Victims
The postponements followed Lopez tweeting that she was feeling "so broken" after the Route 91 incident yesterday (Oct. 2). Not long after, she shared a list of several blood donation centers where people can donate to help the victims in need.

04 October 2017
Anheuser Busch Inbev NV (BUD) Stake Increased by Clarkston Capital Partners LLC
The Connecticut-based Mark Sheptoff Planning Limited Liability Co has invested 0.35% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). It increased, as 27 investors sold USCR shares while 49 reduced holdings. 117 funds opened positions while 502 raised stakes.

04 October 2017
US Against UN Ban On Death Penalty For Homosexuality
According to Forbes , 27 nations voted in favor of the resolution , 13 voted against it , and 7 abstained. The resolution notably doesn't call for the end to the death penalty.

04 October 2017
NBA Makes Drastic Changes To All-Star Game Format
The leading vote-getter from each conference will serve as a captain, and will get to hand-pick their sides out of each pool. TNT will reveal the All-Star Game starters and captains on Thursday, Jan. 18 and unveil the reserves on Tuesday, Jan. 23.

04 October 2017
Host Hotels & Resorts, Inc. (NYSE:HST) Shares Bought by Ameriprise Financial Inc
Sei Investments Co holds 0.02% in Bloomin' Brands Inc (NASDAQ:BLMN) or 279,592 shares. 1,000 are held by Wfg Ltd Partnership. The firm owned 2,163,739 shares of the real estate investment trust's stock after selling 84,610 shares during the period.

04 October 2017
Alder Biopharmaceuticals (ALDR) Analysts See $-1.21 EPS; Zagg (ZAGG) Sentiment Is 1.14
Baird Financial Group Inc. raised its holdings in shares of Alder BioPharmaceuticals by 7.9% during the first quarter. The analyst recommendations from a month ago are 2 Buy, 0 Overweight, 0 Sell, 0 Hold and 0 Underweight.

03 October 2017
Trading Watch: Shares of MGM Resorts International (MGM) Noted Over Chikou
The stock of MGM Resorts International (NYSE: MGM ) earned "Outperform" rating by Telsey Advisory Group on Friday, December 9. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable.

03 October 2017
Revenue Approximations Analysis: Varian Medical Systems, Inc
Point72 Asset Management L.P. purchased a new stake in Varian Medical Systems during the 1st quarter valued at about $32,433,000. Therefore 36% are positive. 05/11/2017 - Varian Medical Systems, Inc. had its "buy" rating reiterated by analysts at Jefferies.

03 October 2017
Louisville Releases Letters Sent To Rick Pitino & Tom Jurich
Section 6.5 of Jurich's contract states that he's to be given 90 days' advance notice of termination without cause. The University of Louisville's interim president will name an acting athletic director Tuesday afternoon.